Getinge Group Appoints Harald F. Stock as New President and CEO of
ArjoHuntleigh and Executive Vice President Extended Care Business Area
GETINGE, Sweden -- December 9, 2013
Getinge Group has appointed Harald F. Stock as new President and Chief
Executive Officer of ArjoHuntleigh, and Executive Vice President Extended Care
Business Area. Harald will be a member of the Getinge Group Executive
Management Team and will succeed Alex Myers, who will pursue a new role
outside of the group.
Harald Stock has almost twenty years of experience and a successful track
record in the healthcare industry. He most recently served as the chief
executive officer of the Grünenthal Group, a globally operating, family-owned,
research-oriented pharmaceutical company. Previously, he held executive
positions with the Roche Group and at DePuy, the Orthopaedics Division of
Johnson & Johnson. Harald holds a PhD. in inorganic chemistry from University
of Heidelberg, Germany.
“I am very pleased to welcome Harald to the Group. Harald has vast experience
in the industry and a very strong commercial background. He has a great track
record of successfully improving business performance and will be an asset to
the team,” says Johan Malmquist, CEO Getinge Group. “I would also like to
express my gratitude to Alex Myers for his professional and dedicated work
during his five years with ArjoHuntleigh and the Getinge Group’s Extended Care
business area. Alex has developed the business and established a competitive
structure following the merger of Arjo and Huntleigh. I wish him all the best
and good luck with his new challenges as President & CEO of the global bed
manufacturer, Hilding Anders Group.”
Harald will assume his new position as of 1 January 2014 and will report to
Johan Malmquist, CEO Getinge Group.
GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency within healthcare and
life sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and
MAQUET. ArjoHuntleigh focuses on patient mobility and wound management
solutions. GETINGE provides solutions for infection control within healthcare
and contamination prevention within life sciences. MAQUET specializes in
solutions, therapies and products for surgical interventions, interventional
cardiology and intensive care.
The information is such that Getinge AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading Act.
This information was brought to you by Cision http://news.cision.com
CEO, Getinge Group
Tel: +46 10 335 00 00
Press spacebar to pause and continue. Press esc to stop.